Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Center for COMBAT Research, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Mil Med. 2023 Nov 3;188(11-12):e3482-e3487. doi: 10.1093/milmed/usad189.
Airway compromise is the second leading cause of potentially preventable prehospital combat death. Endotracheal intubation (ETI) remains the most common role 1 airway intervention. Video laryngoscopy (VL) is superior to direct laryngoscopy (DL) for first-attempt intubation, especially in less-experienced providers and for trauma patients. The cost has been a major challenge in pushing VL technology far-forward; however, the cost of equipment continues to become more affordable. We conducted a market analysis of VL devices under $10,000 for possible options for role 1.
We searched Google, PubMed, and the Food and Drug Administration database from August 2022 to January 2023 with a combination of several keywords to identify current VL market options under $10,000. After identifying relevant manufacturers, we then reviewed individual manufacturer or distributor websites for pricing data and system specifications. We noted several characteristics regarding VL device design for comparison. These include monitor features, size, modularity, system durability, battery life, and reusability. When necessary, we requested formal price quotes from respective companies.
We identified 17 VL options under $10,000 available for purchase, 14 of which were priced below $5,000 for individual units. Infium (n = 3) and Vimed Medical (n = 4) provided the largest number of unique models. VL options under $10,000 exist in both reusable and disposable modalities. These modalities included separate monitors as well as monitors attached to the VL handle. Disposable options, on a per-unit basis, cost less than reusable options.
Several VL options exist within our goal price point in both reusable and disposable options. Clinical studies assessing the technology performance of ETI and deliberate downselection are needed to identify the most cost-effective solution for role 1 dispersion.
气道阻塞是导致有潜在预防可能的战创伤院前死亡的第二大原因。经口气管插管（ETI）仍然是最常见的一级气道干预手段。视频喉镜（VL）在首次尝试插管时优于直接喉镜（DL），尤其是在经验较少的提供者和创伤患者中。该技术的成本一直是推动 VL 技术发展的主要挑战；然而，设备的成本继续变得更加负担得起。我们对 10000 美元以下的 VL 设备进行了市场分析，以寻找一级角色的可能选择。
我们于 2022 年 8 月至 2023 年 1 月期间，通过在谷歌、PubMed 和美国食品和药物管理局数据库中搜索了几个关键词的组合，以确定 10000 美元以下的当前 VL 市场选择。在确定相关制造商后，我们随后审查了每个制造商或分销商的网站，以获取定价数据和系统规格。我们注意到 VL 设备设计的几个特点用于比较。这些包括监视器功能、尺寸、模块化、系统耐用性、电池寿命和可重复使用性。必要时，我们向各公司请求正式报价。
我们确定了 17 种 10000 美元以下可供购买的 VL 选择，其中 14 种的单价低于 5000 美元。Infium（n = 3）和 Vimed Medical（n = 4）提供了最多独特型号。10000 美元以下的 VL 选择既有可重复使用的，也有一次性使用的。这些模式包括单独的监视器以及连接到 VL 手柄的监视器。一次性选择的单价低于可重复使用的选择。
在我们的目标价格范围内，既有可重复使用的，也有一次性的 VL 选择。需要进行评估 ETI 技术性能和故意选择的临床研究，以确定一级分散的最具成本效益的解决方案。
